Nankivell, P. Et Al. 2013. Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. BRITISH JOURNAL OF CANCER , vol.109, no.11 , 2864-2874.

Nankivell, P., Williams, H., Mcconkey, C., Webster, K., High, A., Maclennan, K., ... Senguven, B.(2013). Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. BRITISH JOURNAL OF CANCER , vol.109, no.11, 2864-2874.

Nankivell, P. Et Al. "Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia," BRITISH JOURNAL OF CANCER , vol.109, no.11, 2864-2874, 2013

Nankivell, P. Et Al. "Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia." BRITISH JOURNAL OF CANCER , vol.109, no.11, pp.2864-2874, 2013

Nankivell, P. Et Al. (2013) . "Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia." BRITISH JOURNAL OF CANCER , vol.109, no.11, pp.2864-2874.

@article{article, author={P. Nankivell Et Al. }, title={Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia}, journal={BRITISH JOURNAL OF CANCER}, year=2013, pages={2864-2874} }